Role of shrinkage in esophageal–gastric junction cancer-Reference-Cited by-同舟云学术

Role of shrinkage in esophageal–gastric junction cancer

Published:2023-06 Issue:6 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Leongito Maddalena¹^ORCID,Palaia Raffaele¹,Casaretti Rossana²,Tatangelo Fabiana³,Foschini Francesca²,Di Mauro Annabella³,Belli Andrea¹,Albino Vittorio¹

Affiliation:

1. Chirurgia oncologica gastro‐pancreatica Istituto Nazionale Tumori – IRCCS – Fondazione G. Pascale Napoli Italy

2. Oncologia Istituto Nazionale Tumori – IRCCS – Fondazione G. Pascale Napoli Italy

3. Anatomia patologica Istituto Nazionale Tumori – IRCCS – Fondazione G. Pascale Napoli Italy

Abstract

The esophagus undergoes shrinkage after resection and fixation. The surgical in situ margin is greater than the specimen margin, measured by the pathologist. The length of disease‐free margins is critical to therapeutic planning. We propose specimen fixing to avoid discrepancies between the operative finding and the pathological result.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.6982

Reference20 articles.

1. Epidemiology of gastric cancer

2. Epidemiology of gastric cancer: global trends, risk factors and prevention

3. The right approach to carcinoma of the cardia: preliminary results;Hill S;Eur J Surg Oncol,1992

4. Shrinkage of the Esophagus after Resection for Carcinoma

5. Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.